Culture-negative osteoarticular infections in the era of community-associated methicillin-resistant staphylococcus aureus

Pediatric Infectious Disease Journal

Volumn 30, Issue 6, 2011, Pages 523-525

  Williams, Derek J ^a,c   Deis, Jamie N ^b   Tardy, Joshua ^a   Creech, C Buddy ^a  

^a MONROE CARELL JR CHILDREN S HOSPITAL AT VANDERBILT   (United States)

^b WAKE FOREST UNIVERSITY HEALTH SCIENCES   (United States)

^c NONE   (United States)

Author keywords

community associated MRSA; osteomyelitis; septic arthritis; treatment outcomes

Indexed keywords

ANTIBIOTIC AGENT; BETA LACTAM DERIVATIVE; CLINDAMYCIN; VANCOMYCIN;

ARTICLE; BACTERIUM CULTURE; BONE INFECTION; CHILD; DISEASE SEVERITY; FEMALE; HUMAN; INFANT; MAJOR CLINICAL STUDY; MALE; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS INFECTION; OSTEOARTICULAR INFECTION; PRIORITY JOURNAL; SCHOOL CHILD;

EID: 79957979708     PISSN: 08913668     EISSN: 15320987     Source Type: Journal    
DOI: 10.1097/INF.0b013e318207a7a5     Document Type: Article

References (12)

1. Saavedra-Lozano J, Mejias A, Ahmad N, et al. Changing trends in acute osteomyelitis in children: impact of methicillin-resistant Staphylococcus aureus infections. J Pediatr Orthop. 2008;28:569-575.
2. Arnold SR, Elias D, Buckingham SC, et al. Changing patterns of acute hematogenous osteomyelitis and septic arthritis: emergence of communityassociated methicillin-resistant Staphylococcus aureus. J Pediatr Orthop. 2006;26:703-708. (Pubitemid 44655534)
3. Hawkshead JJ III, Patel NB, Steele RW, et al. Comparative severity of pediatric osteomyelitis attributable to methicillin-resistant versus methicillin-sensitive Staphylococcus aureus. J Pediatr Orthop. 2009;29:85-90.
4. Ruebner R, Keren R, Coffin S, et al. Complications of central venous catheters used for the treatment of acute hematogenous osteomyelitis. Pediatrics. 2006;117:1210-1215. (Pubitemid 46071514)
5. Zaoutis T, Localio AR, Leckerman K, et al. Prolonged intravenous therapy versus early transition to oral antimicrobial therapy for acute osteomyelitis in children. Pediatrics. 2009;123:636-642.
6. Peltola H, Paakkonen M, Kallio P, et al. Prospective, randomized trial of 10 days versus 30 days of antimicrobial treatment, including a short-term course of parenteral therapy, for childhood septic arthritis. Clin Infect Dis. 2009;48:1201-1210.
7. Jagodzinski NA, Kanwar R, Graham K, et al. Prospective evaluation of a shortened regimen of treatment for acute osteomyelitis and septic arthritis in children. J Pediatr Orthop. 2009;29:518-525.
8. Darley ES, MacGowan AP. Antibiotic treatment of gram-positive bone and joint infections. J Antimicrob Chemother. 2004;53:928-935. (Pubitemid 38811422)
9. Chang WS, Chiu NC, Chi H, et al. Comparison of the characteristics of culture-negative versus culture-positive septic arthritis in children. J Microbiol Immunol Infect. 2005;38:189-193. (Pubitemid 40992162)
10. Yagupsky P, Dagan R, Howard CW, et al. High prevalence of Kingella kingae in joint fluid from children with septic arthritis revealed by the BACTEC blood culture system. J Clin Microbiol. 1992;30:1278-1281.
11. Chometon S, Benito Y, Chaker M, et al. Specific real-time polymerase chain reaction places Kingella kingae as the most common cause of osteoarticular infections in young children. Pediatr Infect Dis J. 2007;26:377-381. (Pubitemid 46789316)
12. Ilharreborde B, Bidet P, Lorrot M, et al. New real-time PCR-based method for Kingella kingae DNA detection: application to samples collected from 89 children with acute arthritis. J Clin Microbiol. 2009;47:1837-1841.